L-arginine stimulates NO-dependent vasodilation in healthy humans-effect of somatostatin pretreatment

Journal of Investigative Medicine

Volumn 47, Issue 1, 1999, Pages 43-50

  Bode Böger, Stefanie M ^a   Böger, Rainer H ^a   Löffler, Matthias ^a   Tsikas, Dimitrios ^a   Brabant, Georg ^a   Frölich, Jürgen C ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cyclic GMP; Growth hormone; Insulin; Insulin like growth factor 1; Nitric oxide

Indexed keywords

ARGININE; HUMAN GROWTH HORMONE; INSULIN; NITRIC OXIDE; SOMATOSTATIN;

ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; DRUG EFFECT; HUMAN; MALE; PHYSIOLOGY; VASCULAR RESISTANCE; VASODILATATION;

ADULT; ARGININE; BLOOD PRESSURE; HUMAN GROWTH HORMONE; HUMANS; INSULIN; MALE; NITRIC OXIDE; SOMATOSTATIN; VASCULAR RESISTANCE; VASODILATION;

EID: 0032602366     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
2. Bode-Böger SM, Böger RH, Creutzig A, Tsikas D, Gutzki FM, Alexander K, Frölich JC. L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin Sci 1994;87:303-10.
3. Bode-Böger SM, Böger RH, Alfke H, Heinzel D, Tsikas D, Creutzig A, Alexander K, Frölich JC. L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study. Circulation 1996;93:85-90.
4. Kanno K, Hirata Y, Emori T. Ohta K, Eguchi S, Imai T, Marumo F. L-arginine infusion induces hypotension and diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans. Clin Exp Pharmacol Physiol 1992;19:619-25.
5. Rhodes PM, Leone AM, Francis PL, Struthers AD, Moncada S. The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem Biophys Res Commun 1995;209:590-6.
6. Kharitonov SA, Lubec G, Lubec B, Hjelm M, Barnes PJ. L-arginine increases exhaled nitric oxide in normal humans. Clin Sci 1995;88:135-9.
7. Merimee TJ, Rabinovitz D, Riggs L, Burgessi JA, Rimoin DL Cokusick VA. Plasma growth hormone after arginine injection. N Engl J Med 1967;276:434.
8. Gerich JE, Lorenzi M, Schneider V, Kwan CW, Karam JH, Guillemin R, Forsham PH. Inhibiltion of pancreatic glucagon responses to arginine by somatostatin in normal man and in insulin-dependent diabetics. Diabetes 1974;23:876-80.
9. Saccá L, Cittadini A, Fazio S. Growth hormone and the heart. Endocr Rev 1994;15:555-73.
10. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991;87:2246-52.
11. Giugliano D, Marfella R, Verrazzo G, Acampora R, Coppola L, Cozzolino D, D'Onofrio F. The vascular effects of L-arginine in humans. J Clin Invest 1997;99:433-8.
12. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide accounts for insulin's vascular effects in humans. J Clin Invest 1994;94:2511-15.
13. Krieg RJ, Santos F, Chan JCM. Growth hormone, insulin-like growth factor and the kidney. Kidney Int 1995;48:321-36.
14. Haylor J, Singh I, El Nahas AM. Nitric oxide inhibitor prevents vasodilation by insulin-like growth factor-1. Kidney Int 1991;39:333-5.
15. Böger RH, Skamira C, Bode-Böger SM, Brabant G, von zur Mühlen A, Frölich JC. Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study. J Clin Invest 1996;98:2706-13.
16. Koerker DJ, Ruch W, Chidecke E, Palmer J, Goodner CJ, Ensinck J, Gale CC. Somatostatin: hypothalamic inhibitor of the endocrine pancreas. Science 1974;184:482-4.
17. Mortimer CH, Tunbridge WM, Carr D, Yeomans L, Lind T, Coy OH, Bloom SR, Kastin A, Mallison CN, Besser GM, Schally AV, Hall R. Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet I 1974;697-701.
18. Guillemin R, Gerich JE. Somatostatin: physiological and clinical significance. Annu Rev Med 1976;27:379-88.
19. Kubicek WG, Karnegis JN, Patterson RP, Witsoe DA, Mattson RM. Development and evaluation of an impedance cardiac output system. Aerospace Med 1966;37:1208-12.
20. Belardinelli R, Ciampani N, Costanini C, Blandini A, Purcaro A. Comparison of impedance cardiograrphy with thermodilution and direct Fick methods for noninvasive measurement of stroke volume and cardiac output during incremental exercise in patients with ischemic cardiomyopathy. Am J Cardiol 1996;77:1293-1301.
21. Breithaupt K, Erb K, Neumann B, Wolf GK, Beiz GG. Comparison of four noninvasive techniques to measure stroke volume; dual beam Doppler echoaortography, electrical impedance cardiography, mechanosphygmography, and M-mode echocardiography on the left ventricle. Am J Noninvas Cardiol 1990;4:203-9.
22. 15N-labelled analogs. J Chromatogr B, Biomed Appl 1994;661:185-91.
23. Tsikas D, Gutzki FM, Rossa S, Bauer H, Neumann C, Dockendorff K, Sandmann J, Frölich JC. Measurement of nitrite and nitrate in biological fluids by gas chromatography-mass spectrometry and by the Griess assay: problems with the Griess assay-solutions by gas chromatography-mass spectrometry. Anal Biochem 1997;244:208-20.
24. Bode-Böger SM, Böger RH, Kienke S, Junker W, Fröhch JC. Elevated L-arginine/dimethyla L-arginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun 1996;219:598-603.
25. Smulders RA, Aarsed M, Teerlink T, deVries PMJM, van Kamp GJ, Donker AJM, Sehouwer CDA. Haemodynamic and biochemical responses to L-arginine and L-lysine infusions in normal subjects: L-arginine-induced vasodilatation cannot be explained by unspecific effects of cationic amino acids. Clin Sci 1997;92:367-74.
26. Böger RH, Bode-Böger SM, Thiele W, Junker W, Alexander K, Frölich JC. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 1997;95:2068-74.
27. Pollock JS, Förstermann U, Mitchell JA, Warner TD, Schmidt HHHW, Nakane M, Murad F. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA 1991;88:10480-84.
28. Vallance P, Leone A, Calver A, Collier J, Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 1992;20 (Suppl. 12):S60-2.
29. Caidahl K, Edén S, Bengtsson BA. Cardiovascular and renal effects of growth hormone. Clin Endocrinol 1994;40:393-400.
30. G-monomethyl-L-arginine inhibits the blood flow but not the insulin-like response of forearm muscle to IGF-1. J Clin Invest 1996;97:1319-28.
31. MacAllister RJ, Calver AL, Collier J, Edwards CMB, Herredos B, Nussey SS, Vallance P. Vascular and hormonal responses to arginine: provision of substrate for nitric oxide or non-specific effect? Clin Sci 1995;89:183-90.
32. Bar RS, Boes M, Dake BL, Booth BA, Henley SA, Sandra A. Insulin, insulin-like growth factors, and vascular endothelium. Am J Med 1988;85 (Suppl 5a):59-70.
33. Tsukahara H, Gordienko DV, Tonshoff B, Gelato MC, Goligorsky MS. Direct demonstration of insulin-like growth factor-1-induced nitric oxide production by endothelial cells. Kidney Int 1994;45:598-604.
34. Smulders RA, Stehouwer CDA, Olthoff CG, van Kamp GJ, Teerlink T, deVries PMJM, Donker AJM. Plasma endothelin levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus. Clin Sci 1994;87:37-43.
35. Winquist RJ, Faison EP, Waldman SA, Schwartz K, Murad F, Rapoport RM. Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle. Proc Natl Acad Sci USA 1984;81:7661-4.
36. Calver A, Collier J, Vallance P. Dilator actions of arginine in human peripheral vasculature. Clin Sci 1991;81:695-700.